Literature DB >> 19803778

Genetic influences on individual differences in nicotine glucuronidation.

Christina N Lessov-Schlaggar1, Neal L Benowitz, Peyton Jacob, Gary E Swan.   

Abstract

Nicotine and its primary oxidative metabolites are metabolized in part by glucuronidation. Genetic variation in UGT isoenzymes that catalyze glucuronidation activity suggests that variation in glucuronidation rate is in part genetically determined. The relative contribution of genetic and environmental sources to individual differences in the rate of glucuronidation of nicotine, cotinine, and trans-3'-hydroxycotinine was estimated in a twin study of nicotine pharmacokinetics. Glucuronidation rate was defined using measures that either accounted for variability in renal clearance or assumed the same relative renal clearance of parent drug and glucuronide conjugate across individuals. The former definition resulted in highly correlated nicotine and cotinine glucuronidation measures that were substantially influenced by the combined effect of additive (heritable) and non-additive (dominant and epistatic) genetic effects. These findings suggest that genetic variation in UGT isoenzymes that act in additive and interactive ways is an important determinant of individual variability in nicotine and cotinine metabolism via glucuronidation pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19803778      PMCID: PMC3202423          DOI: 10.1375/twin.12.5.507

Source DB:  PubMed          Journal:  Twin Res Hum Genet        ISSN: 1832-4274            Impact factor:   1.587


  16 in total

1.  Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers.

Authors:  G D Byrd; K M Chang; J M Greene; J D deBethizy
Journal:  Drug Metab Dispos       Date:  1992 Mar-Apr       Impact factor: 3.922

2.  Pharmacogenetics of nicotine metabolism in twins: methods and procedures.

Authors:  Gary E Swan; Neal L Benowitz; Peyton Jacob; Christina N Lessov; Rachel F Tyndale; Kirk Wilhelmsen; Ruth E Krasnow; Mary R McElroy; Sharyn E Moore; Michelle Wambach
Journal:  Twin Res       Date:  2004-10

3.  Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.

Authors:  M Nakajima; T Yamamoto; K Nunoya; T Yokoi; K Nagashima; K Inoue; Y Funae; N Shimada; T Kamataki; Y Kuroiwa
Journal:  J Pharmacol Exp Ther       Date:  1996-05       Impact factor: 4.030

4.  Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence.

Authors:  Gary E Swan; Neal L Benowitz; Christina N Lessov; Peyton Jacob; Rachel F Tyndale; Kirk Wilhelmsen
Journal:  Pharmacogenet Genomics       Date:  2005-02       Impact factor: 2.089

Review 5.  Metabolism and disposition kinetics of nicotine.

Authors:  Janne Hukkanen; Peyton Jacob; Neal L Benowitz
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

6.  N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases.

Authors:  Omar Ghosheh; Edward M Hawes
Journal:  Drug Metab Dispos       Date:  2002-09       Impact factor: 3.922

7.  Genetic influences in the variation in renal clearance of nicotine and cotinine.

Authors:  N L Benowitz; C N Lessov-Schlaggar; G E Swan
Journal:  Clin Pharmacol Ther       Date:  2008-04-02       Impact factor: 6.875

8.  Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine.

Authors:  N L Benowitz; P Jacob; I Fong; S Gupta
Journal:  J Pharmacol Exp Ther       Date:  1994-01       Impact factor: 4.030

9.  Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.

Authors:  Hiroyuki Yamanaka; Miki Nakajima; Miki Katoh; Ayano Kanoh; Osamu Tamura; Hiroyuki Ishibashi; Tsuyoshi Yokoi
Journal:  Drug Metab Dispos       Date:  2004-10-06       Impact factor: 3.922

10.  Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.

Authors:  Ursula Ehmer; Arndt Vogel; Jan Karl Schütte; Britta Krone; Michael P Manns; Christian P Strassburg
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

View more
  7 in total

1.  UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.

Authors:  Catherine A Wassenaar; David V Conti; Soma Das; Peixian Chen; Edwin H Cook; Mark J Ratain; Neal L Benowitz; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

2.  EFFECT OF CYP2A6*4 GENETIC POLYMORPHISMS ON SMOKING BEHAVIORS AND NICOTINE DEPENDENCE IN A GENERAL POPULATION OF JAPANESE MEN.

Authors:  Teruna Ito; Masayoshi Tsuji; Yayoi Mori; Hideyuki Kanda; Tomoo Hidaka; Takeyasu Kakamu; Tomohiro Kumagai; Takehito Hayakawa; Yoneatsu Osaki; And Tetsuhito Fukushima
Journal:  Fukushima J Med Sci       Date:  2015-09-11

3.  Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.

Authors:  Kannan Rangiah; Wei-Ting Hwang; Clementina Mesaros; Anil Vachani; Ian A Blair
Journal:  Bioanalysis       Date:  2011-04       Impact factor: 2.681

4.  The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans.

Authors:  A Joseph Bloom; Linda B von Weymarn; Maribel Martinez; Laura J Bierut; Alison Goate; Sharon E Murphy
Journal:  Pharmacogenet Genomics       Date:  2013-12       Impact factor: 2.089

5.  The Twin Research Registry at SRI International.

Authors:  Ruth E Krasnow; Lisa M Jack; Christina N Lessov-Schlaggar; Andrew W Bergen; Gary E Swan
Journal:  Twin Res Hum Genet       Date:  2012-10-19       Impact factor: 1.587

6.  Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation.

Authors:  Huijie Li; Qiang Wang; Suyun Li; Chongqi Jia
Journal:  Genet Res (Camb)       Date:  2022-09-28       Impact factor: 1.375

7.  Genetic variants in CYP2A6 and UGT1A9 genes associated with urinary nicotine metabolites in young Mexican smokers.

Authors:  Gissela Borrego-Soto; Yadira X Perez-Paramo; Gang Chen; Sandra K Santuario-Facio; Jesus Santos-Guzman; Rodolfo Posadas-Valay; Fatima M Alvarado-Monroy; Isaias Balderas-Renteria; Ramses Medina-Gonzalez; Rocio Ortiz-Lopez; Philip Lazarus; Augusto Rojas-Martinez
Journal:  Pharmacogenomics J       Date:  2020-01-21       Impact factor: 3.550

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.